EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiological insights and genetic diversity of the Duffy binding protein of Plasmodium vivax in Duffy-negative Cameroonians

Cheikh Cambel Dieng iD, Rene Teh Ning, Canelle Kipayko, Regan Elizabeth Schroeder, Nontokozo Mdluli-Berndt, Bate Ayukenchengamba, Zidedine Nematchoua Weyou, Tabi Doris Sona, Ambendekson Elizabeth Reward, Guofa Zhou, Irene Sumbele Ngole Ule, Helen Kuokuo Kimbi und 1 weitere

PLOS Neglected Tropical Diseases · 04.06.2026 · 20 (6) · e0014404

DOI: 10.1371/journal.pntd.0014404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 04.06.2026. Verfasst von Cheikh Cambel Dieng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Protozoan Proteins, Plasmodium vivax, Genetic Variation, Malaria, Vivax. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Malaria remains a major public health concern in sub-Saharan Africa. Plasmodium vivax ( P. vivax ), historically considered rare due to the predominance of Duffy-negative individuals, is increasingly reported in Central and West Africa. The ability of P. vivax to infect Duffy-negative populations challenges long-standing assumptions regarding parasite invasion biology and highlight surveillance gaps across Africa. Methodology/Principal findings This study investigated P. vivax prevalence and genetic diversity across three ecological zones in Cameroon. A total of 1,373 samples were screened by microscopy, rapid diagnostic tests (RDTs), and qPCR; and all participants were genotyped for Duffy antigen status. PvDBP1 region II was successfully sequenced from 75 P. vivax isolates. P. vivax prevalence was 10.8% among hospital patients (86/793) and 5.5% in community participants (32/580), and all confirmed infections occurred in Duffy-negative individuals. Hospital infections exhibited significantly higher parasitemia than asymptomatic cases. PvLDH-based RDTs failed to detect over 85% of qPCR-confirmed infections. Genetic analysis of PvDBP1 identified eight nonsynonymous mutations, with I379L (74.1%) and E225K (61.3%) as the most common variants, suggesting possible adaptive evolution. Phylogenetic analysis clustered Cameroonian P. viv axisolates with those from Botswana, distinct from East African and Asian lineages, indicating regional adaptation and potential gene flow within Central-Southern Africa. Conclusion/Significance This study provides the first integrated epidemiological and PvDBP1 genetic characterization of P. vivax infections in Duffy-negative Central Africans, revealing widespread subclinical infections and poor diagnostic performance of current PvLDH-based RDTs. The observed genetic signatures of adaptation highlight the urgent need to prioritize P. vivax within national malaria programs and investigate alternative invasion pathways beyond PvDBP1 to guide improved diagnostic and vaccine strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protozoan ProteinsPlasmodium vivaxGenetic VariationMalaria, VivaxAntigens, ProtozoanDuffy Blood-Group SystemReceptors, Cell SurfaceCameroonHumansFemaleMalePrevalenceAdultGenotypeAdolescentYoung AdultChildMiddle AgedChild, PreschoolPhylogeny

Substanzen

Protozoan ProteinsAntigens, ProtozoanDuffy antigen binding protein, PlasmodiumDuffy Blood-Group SystemReceptors, Cell Surface

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, Pennsylvania, United States of America.
  • Department of Animal Biology and Conservation (ABC), Faculty of Science, University of Buea, Buea, Cameroon.
  • Department of Population Health and Disease Prevention, School of Public Health, University of California at Irvine, Irvine, California, United States of America.
  • Department of Biomedical Sciences, University of Bamenda, Bamenda, Bambili, Cameroon.

ORCID-Profile: Cheikh Cambel Dieng

Förderung

  • NIAID NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Dieng, C. C., Ning, R. T., Kipayko, C., Schroeder, R. E., Mdluli-Berndt, N., Ayukenchengamba, B., Nematchoua Weyou, Z., Sona, T. D., Reward, A. E., Zhou, G., Sumbele Ngole Ule, I., Kimbi, H. K., & Lo, E. (2026). Epidemiological insights and genetic diversity of the Duffy binding protein of Plasmodium vivax in Duffy-negative Cameroonians. PLOS Neglected Tropical Diseases, 20(6), e0014404. https://doi.org/10.1371/journal.pntd.0014404

Vancouver

Dieng CC, Ning RT, Kipayko C, Schroeder RE, Mdluli-Berndt N, Ayukenchengamba B, et al. Epidemiological insights and genetic diversity of the Duffy binding protein of Plasmodium vivax in Duffy-negative Cameroonians. PLOS Neglected Tropical Diseases. 2026;20(6):e0014404. doi:10.1371/journal.pntd.0014404

BibTeX
@article{Dieng2026,
  author = {Dieng, Cheikh Cambel and Ning, Rene Teh and Kipayko, Canelle and Schroeder, Regan Elizabeth and Mdluli-Berndt, Nontokozo and Ayukenchengamba, Bate and Nematchoua Weyou, Zidedine and Sona, Tabi Doris and Reward, Ambendekson Elizabeth and Zhou, Guofa and Sumbele Ngole Ule, Irene and Kimbi, Helen Kuokuo and Lo, Eugenia},
  title = {Epidemiological insights and genetic diversity of the Duffy binding protein of Plasmodium vivax in Duffy-negative Cameroonians},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {e0014404},
  doi = {10.1371/journal.pntd.0014404}
}
Kostenlos starten →